|
Oral cancer Articles
Oral cancer News : Long Term Use Of Oral Bisphosphonates May Double Risk Of Esophageal Cancer Fri, 03 Sep 2010 01:23:25 GMT People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing esophageal cancer (cancer of the gullet), according to a new study.Oral cancer News : Long term use of oral bisphosphonates may double risk of esophageal cancer Thu, 02 Sep 2010 23:31:59 GMT People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing esophageal cancer (cancer of the gullet), according to a new study published on bmj.com today.Long term use of oral bisphosphonates may double risk of esophageal cancer Thu, 02 Sep 2010 23:32:19 GMT People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published in the British Medical Journal today.The Cancer-Causing Sex Virus Sat, 04 Sep 2010 04:54:13 GMT HPV, known for causing cervical cancer, is emerging as the leading cause of throat cancer in men.Osteoporosis meds increase risk of cancer Sat, 04 Sep 2010 07:30:33 GMT Oral ingestion of bisphosphonates may double the patient’s risk of developing cancer of the esophagus, a UK report released Friday said of the popular osteoporosis drug.Cancer drug gets funding Fri, 03 Sep 2010 00:34:51 GMT People with advanced lung cancer could find it much easier to be treated at home with Pharmac announcing an oral cancer drug will now be funded.Osteoporosis drug linked to cancer Sat, 04 Sep 2010 00:45:56 GMT OXFORD, England, Sept. 3 (UPI) -- Long-term use of oral bisphosphonates -- used to prevent bone loss -- may double the risk of developing esophageal cancer, researchers in Britain say. Osteoporosis - Esophageal cancer - Health - Cancer - EnglandOsteoporosis Drugs May Up Esophageal Cancer Risk Fri, 03 Sep 2010 12:05:29 GMT A second look at British registry data indicates that esophageal cancer may be more common after all in patients taking oral bisphosphonate drugs, a type of drug used to treat osteoporosis, for long periods. Health - Esophageal cancer - Osteoporosis - Cancer - Conditions and DiseasesOral sex, STDs causing increase in oral cancers Thu, 02 Sep 2010 07:38:07 GMT The same sexually transmitted virus that causes cervical cancer is fuelling the growth of some types of oral cancers -- and oral sex is believed to be the main conduit, according to experts in B.C. and around the world.Osteoporosis Drugs May Be Linked to Cancer Risk Sat, 04 Sep 2010 07:30:13 GMT Title: Osteoporosis Drugs May Be Linked to Cancer Risk Category: Health News Created: 9/3/2010 8:58:00 AM Last Editorial Review: 9/3/2010 8:58:19 AMWhat You Need to Know About Throat Cancer Wed, 01 Sep 2010 22:52:22 GMT According to the Oral Cancer Foundation, 50,000 Americans will be diagnosed with pharyngeal or laryngeal cancer this year. More than 13,000 people will die from the disease. Here's what you need to know. Cancer - Health - Conditions and Diseases - Head and Neck - OrganizationsOsteoporosis Drugs May Be Linked to Cancer Risk Thu, 02 Sep 2010 23:30:07 GMT The long-term use of oral bisphosphonate osteoporosis drugs such as Actonel, Boniva, and Fosamax may be associated with a doubling in esophageal cancer risk, but the risk to individual users remains small, researchers say.Drugs used to treat osteoporosis not linked with higher risk of esophageal cancer Fri, 03 Sep 2010 01:22:55 GMT Although some reports have suggested a link between the use of oral bisphosphonates (drugs that prevent the loss of bone mass) and esophageal cancer, analysis of medical data from more than 80,000 patients in the United Kingdom found that use of these drugs was not significantly associated with new cases of esophageal or gastric cancer, according to a new study.Oral surgeon released pending trial on cocaine charges Thu, 02 Sep 2010 23:00:40 GMT A federal judge on Thursday released Billings oral surgeonJerome Daniel Mancuso from jail pending trial on cocainecharges.Osteoporosis drug ups cancer risk Fri, 03 Sep 2010 01:23:41 GMT LONDON - A DRUG taken by more than a million people with osteoporosis could double their risk of developing cancer of the oesophagus, a study has found. Those who have taken oral bisphosphonates for five years or more are twice as likely to develop the cancer than those who have not, according to an analysis of medical records by the Oxford University's Cancer Epidemiology Unit. It studied data ...Bone-building drugs double the risk of esophageal cancer, but the risk is still small Fri, 03 Sep 2010 20:02:17 GMT The family of bone-building drugs that includes Fosamax, Actonel and Boniva can double the risk of developing throat cancer, researchers reported Thursday in the latest development in what has become a confusing discussion. Other studies have reported no increase, but even if the newest finding is correct, the risk is still quite small--about two cases per 1,000 people between age 60 and 79 ...Cancer risk 'can be doubled' by taknig drugs to fight bone thinning Fri, 03 Sep 2010 09:42:11 GMT Hundreds of thousands of women taking drugs to combat bone thinning could be doubling their risk of cancer of the oesophagus, warn British researchers.Dentists using more accurate checkup to screen for oral cancer Wed, 01 Sep 2010 23:10:09 GMT NEW ORLEANS -- Actor Michael Douglas is making news after doctors found he has stage 4 throat cancer. It's a type of cancer often times caused by smoking and alcohol. And now local dentists have a way to find oral cancers at an earlier stage. Debbie Stagni is getting ready to have a type of cancer screening that she's never had before. "Cancer is no stranger to my family, so any type of ...Common Osteoporosis Drug Linked To Higher Risk Of Oesophageal Cancer Fri, 03 Sep 2010 12:26:31 GMT A new UK study that followed a large number of people found that those who took 10 or more prescriptions for oral bisphosphonates, a group of drugs commonly used to treat the bone disease osteoporosis, were at higher risk of developing oesophageal cancer. You can read about the research behind this finding in a paper published online in the British Medical Journal, BMJ on 2 September...Osteoporosis drug 'doubles cancer risk' Fri, 03 Sep 2010 06:43:56 GMT London, Sep 03 : A new study has shown that people who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet).Lung cancer drug will be funded Fri, 03 Sep 2010 03:05:01 GMT Taxpayer funding of an expensive lung-cancer drug which has produced amazing, life-saving results for some patients will be announced today.The Herald understands the Government drug funding agency Pharmac will, from October...Dentist hosts oral cancer fundraiser Tue, 31 Aug 2010 21:56:32 GMT Dr. Fred H. Peck DDS is hosting an Oral Cancer Foundation fundraiser at 4 p.m. Friday, Oct. 1, in the parking lot between buildings 8251 and 8261 Cornell Road.Osteoporosis medicines ‘do not run cancer risks’ Sat, 04 Sep 2010 01:36:25 GMT THE Irish Medicines Board said it did not consider certain medications for osteoporosis could increase the risk of cancer.Michael Douglas and Throat Cancer FAQ Fri, 03 Sep 2010 07:30:55 GMT Title: Michael Douglas and Throat Cancer FAQ Category: Health News Created: 9/2/2010 10:56:00 AM Last Editorial Review: 9/2/2010 10:56:02 AMStudy Raises Questions About Osteoporosis Drugs And Esophageal Cancer Fri, 03 Sep 2010 13:10:28 GMT People who take popular osteoporosis medicines may be at higher risk for developing esophageal cancer. But a link is not proved and the odds, in any case, are still low, according to results of a new study.Long-Term Use of Bone Drugs May Be Linked to Esophageal Cancer Thu, 02 Sep 2010 23:08:12 GMT THURSDAY, Sept. 2 (HealthDay News) -- People with osteoporosis who take drugs such as Boniva (ibandronate), Fosamax (alendronate) or Actonel (risedronate) to strengthen their bones may be at an increased risk of esophageal cancer, British researchers report.Common bone drugs linked to esophageal cancer risk Sat, 04 Sep 2010 04:40:46 GMT LONDON (Reuters) - People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of developing cancer of the gullet or esophagus, a British study found on Friday.New lung cancer drug funded in multi-product deal Thu, 02 Sep 2010 22:28:55 GMT Funding a new drug for people with advanced lung cancer and widening access to two other cancer treatments are features of a new agreement PHARMAC has reached with pharmaceutical company Roche Products (NZ) Ltd.Drugs prescribed for osteoporosis linked to increased risk of cancer Fri, 03 Sep 2010 15:08:45 GMT LONG-TERM use of drugs prescribed for osteoporosis may be doubling the users' risk of developing cancer of the oesophagus, a study warns.Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice Fri, 03 Sep 2010 07:29:02 GMT Title: Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice Category: Health News Created: 9/1/2010 2:10:00 PM Last Editorial Review: 9/2/2010Study Raises New Questions About Bone Drugs, Cancer Risk Fri, 03 Sep 2010 14:51:28 GMT Osteoporosis drugs like Actonel, Boniva, and Fosamax could double the risk of esophageal cancer if they are used over a long period of time, according to the findings from a new study. The research, which was funded by Britain’s Medical Research Council and Cancer Research UK, was published today in the British Medical Journal. Actonel, [...]Setting it straight Fri, 03 Sep 2010 08:11:38 GMT A Sept. 2 story about oral cancer incorrectly identified Dr. John Hay, who is a radiation oncologist at the BC Cancer Agency.St. Jude investigators work to improve survival rates for childhood cancer Fri, 03 Sep 2010 08:27:52 GMT Survival rates overall for childhood cancer are almost 80 percent—a marked advance against a disease that was curable in only a small fraction of children 50 years ago. However, despite progress, pediatric cancer remains the leading cause of death due to disease among U.S. children older than 1 year of age.Osteoporosis drug 'doubles cancer risk' Thu, 02 Sep 2010 23:32:01 GMT Drug taken by more than a million people with osteoporosis could increase risk of cancer of the oesophagus, study warns.Drug 'doubles cancer risk' Fri, 03 Sep 2010 00:17:14 GMT A DRUG taken by thousands of osteoporosis sufferers could double their risk of developing cancer of the gullet.Michael Douglas reveals his throat cancer is stage four. What does that mean? Thu, 02 Sep 2010 15:17:47 GMT Michael Douglas’ revelation on the Late Show with David Letterman on Tuesday night that his throat cancer is stage four elicited a gasp from the audience. But what exactly does stage four mean?Osteoporosis drug may double risk of oesophageal cancer Fri, 03 Sep 2010 05:13:06 GMT People taking a certain type of drug for osteoporosis could be doubling the risk of developing cancer of the oesophagus.Health Buzz: Popular Osteoporosis Drugs Linked to Cancer Risk Fri, 03 Sep 2010 16:23:35 GMT How to avoid a C-section; 4 cardio workouts that are creative and fun.Study Raises Questions About Osteoporosis Drugs And Esophageal Cancer Fri, 03 Sep 2010 14:22:58 GMT People who take popular osteoporosis medicines may be at higher risk for developing esophageal cancer. But a link is not proved and the odds, in any case, are still low, according to results of a new study. read moreAfferent Pharmaceuticals Presents Data Supporting Use Of P2X3 Antagonists In Reducing Bone Cancer Pain Fri, 03 Sep 2010 12:27:11 GMT Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecules that target P2X3 receptors, announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist significantly prevented and reversed bone cancer pain behavior in comparison to vehicle controls. These data expand on earlier findings and reveal that a ...Trial To Test Experimental Drug For Advanced Pancreatic Cancer Thu, 02 Sep 2010 14:42:01 GMT Cancer Research UK's Drug Development Office has launched a clinical trial* to test an experimental drug in patients with advanced (Stage IV) pancreatic cancer - one of the most difficult cancers to treat. Around 60 patients with advanced pancreatic cancer will be recruited for the first Phase I/IIclinical trial of a drug called MK-0752** in this disease. MK-0752 will be administered in ...Common bone drugs linked to oesophageal cancer risk Thu, 02 Sep 2010 23:18:54 GMT Source: Reuters * Study is first to find gullet cancer link to long-term use * Bisphosphonates are widely prescribed for bone weakness * Patients should continue on drugs, watch for warning signs By Kate ...Common bone drugs linked to oesophageal cancer risk Thu, 02 Sep 2010 23:01:09 GMT * Study is first to find gullet cancer link to long-term useMichael Douglas Cancer Diagnosis: What You Need to Know Wed, 01 Sep 2010 23:14:05 GMT Actor Michael Douglas was diagnosed with throat cancer, which has avoidable risk factors.Fortis Hospitals launches cancer institute in Mumbai Thu, 02 Sep 2010 07:12:31 GMT Fortis Hospitals has launched a cancer institute at its Mulund facility in Mumbai bringing in comprehensive cancer care with an integrated approach under one roof. This is the second cancer institute launched by Fortis, the first one being launched in Noida near Delhi in July this year.Drugs to fight bone thinning double cancer risk Fri, 03 Sep 2010 09:53:42 GMT London, Sep 3 : Hundreds of thousands of women taking drugs to reverse bone thinning could be doubling their oesophagus (gut) cancer risk.Oral surgeon remains jailed on cocaine charges Tue, 31 Aug 2010 16:09:40 GMT A Billings oral surgeon remained in jail Tuesday after denyingfederal cocaine distribution charges.Montana mid-day news headlines Fri, 03 Sep 2010 18:48:29 GMT A Billings oral surgeon and a former Laurel assistant golf pro, facing federal drug charges for possessing and distributing cocaine, have been released from custody after agreeing to a number of court ordered conditions.Bone disease drug 'link' to cancer Thu, 02 Sep 2010 23:11:46 GMT People taking a certain type of drug for osteoporosis could be doubling the risk of developing cancer of the oesophagus research has found. |
Infectious and parasitic diseases |
|
|
< Home > |
||